NK Imerys S.A.
Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America. The company offers performance minerals, such as additives for plastics, paints and coatings, filtration and life sciences, ceramics, and building products; specialty minerals used as processing aids for extreme work conditions, including refractory, foundry, abrasives, and building chemistry; and graphite and carbon minerals for energy transition and mobile energy markets. It also provides minerals, such as andalusite, ball clay, bentonite, calcium carbonate, carbon black, chamotte, diatomite, feldspar, fused alumina, graphite, halloysite, kaolin, lithium, mica, moler, mullite, perlite, quartz, talc, zeolite, zirconia, and wollastonite. The company serves various markets, such as abrasives, advanced ceramics, animal care, batteries and fuel cells, building materials, ceramics, component manufacturing, cosmetics and personal care, crop production, food and beverage, health, pharmaceuticals and biotechnology, home care, infrastructure and utilities, investment casting, pulp and packaging, and rubber markets. The company was incorporated in 1880 and is headquartered in Paris, France. Imerys S.A. is a subsidiary of Belgian Securities BV.…
Industry Peers
Specialty ChemicalsKey Statistics
About Imerys (EPA: NK)
›
Imerys (EPA: NK) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 12,300 employees.
The shares were at 24.18 EUR on 19 November 2026, up 7.5% over 52 weeks. Its 52-week range is 19.68 EUR to 28.54 EUR: the price is 15.3% below the high and 22.9% above the low.
At a market capitalisation of 2.05B EUR, it trades at 16.6 times trailing earnings and 12.4 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 51% for NK. It pays a dividend yielding 3.05% (it pays out 51% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Imerys reports return on equity of -15.7%, an operating margin of 6.7% and revenue up 6.9% year over year.
Its debt exceeds its cash by 1.46B EUR, a debt-to-equity ratio of 0.86. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Hold; their mean price target of 26.48 EUR is 9.5% above the current price. The next earnings report is expected on 18 February 2027.